JnJ/Pfizer review extended following remedies
The European Commission has extended its review of the planned acquitision by Johnson & Johnson of Pfizer's consumer healthcare division following an offer of remedies to appease antitrust concerns.The European Commission...To view the full article, register now.
Already a subscriber? Click here to view full article